Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cervical Dystonia Patient Registry for the Observation of Botulinum Toxin Type A Efficacy.

Trial Profile

Cervical Dystonia Patient Registry for the Observation of Botulinum Toxin Type A Efficacy.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Jun 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Torticollis
  • Focus Therapeutic Use
  • Acronyms CD PROBE; CD-PROBE
  • Sponsors AbbVie; Allergan
  • Most Recent Events

    • 27 Apr 2023 Results(n=114) assessing Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Anterocollis and Retrocollis presented at the 75th Annual Meeting of the American Academy of Neurology 2023
    • 18 Sep 2022 Results (n=55) assessing real-world treatment outcomes from retrocollis subtype of cervical dystonia presented at the 26th International Congress of Parkinson's Disease and Movement Disorders
    • 25 Jul 2022 According to a AbbVie media release, data from the study will be presented at the TOXINS 2022 Conference to be held in New Orleans.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top